PMVP
PMV Pharmaceuticals, Inc.
Key Financials
Net Income
$-77742000
↓ 32.4%
EPS (Diluted)
$-1.48
↓ 29.8%
Total Assets
$116.6M
↓ 39.1%
Shareholders' Equity
$104.7M
↓ 40.5%
Total Liabilities
$11.8M
↓ 22.1%
Cash & Equivalents
$38.0M
↓ 7.1%
Operating Cash Flow
$-73577000.00
↓ 43.5%
Operating Income
$-86206000
↓ 0.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| SCHEDULE 13G/A | 5/4/2026 | View on SEC |
| ARS | 4/22/2026 | View on SEC |
| DEFA14A | 4/22/2026 | View on SEC |
| DEF 14A | 4/22/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PMVP |
| Company Name | PMV Pharmaceuticals, Inc. |
| CIK | 1699382 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (609) 642-6670 |